RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Valeant Pharmaceuticals International

A collection of news and information related to Valeant Pharmaceuticals International published by this site and its partners.

Top Valeant Pharmaceuticals International Articles see all

Displaying items 1-5
  • Pharmaceutical giant Actavis plans to rename itself Allergan

    Pharmaceutical giant Actavis plans to rename itself Allergan
    Irish pharmaceutical company Actavis said it will adopt the Allergan name after closing a deal to buy the Irvine Botox maker.
  • Allergan sets up meeting to seek shareholder OK of Actavis acquisition

    Allergan Inc., the Irvine company that makes Botox, scheduled a March 10 special meeting to seek shareholder approval of its acquisition by Irish firm Actavis. Actavis agreed in November to pay about $66 billion in cash and stock to acquire Allergan,...

    Salix Pharmaceuticals drops tax inversion deal amid backlash

    Salix Pharmaceuticals drops tax inversion deal amid backlash
    Salix Pharmaceuticals called off its merger with a foreign drug maker Friday, citing the political backlash against tax inversion deals. The deals—in which a company reincorporates abroad to gain lower taxes—drew fire this summer after...

    Allergan, embroiled in takeover battle, raises its profit forecast

    Allergan, embroiled in takeover battle, raises its profit forecast
    Botox maker Allergan lifted its profit outlook Thursday as it tries to stave off a takeover attempt from a Canadian rival. The Irvine-based drug maker said it expects to earn between $1.76 and $1.78 a share during the third quarter, up from its previous...

    Few Allergan execs to keep top jobs in Actavis takeover

    Few Allergan execs to keep top jobs in Actavis takeover
    The soon-to-be owner of Irvine-based Allergan Inc. announced sweeping leadership changes that pass over many current executives including the Botox maker's CEO. Irish pharmaceutical giant Actavis expects to finalize its $66-billion acquisition in the...